The Prognostic Value of the Albumin-to-fibrinogen Ratio in Lung Cancer Patients

Sisi Dai,Lan Yang,Lei Li,Weimin Li
DOI: https://doi.org/10.1183/13993003.congress-2019.pa3059
IF: 6.081
2019-01-01
Lung Cancer
Abstract:Background: Lung cancer is the most lethal cancer in the world and has a poor prognosis. Accumulating studies proved the prognostic value of the albumin-to-fibrinogen ratio (AFR) in various malignancies. However, limited studies have reported the prognostic impact of AFR in lung cancer patients. Aim: to investigate the relationship between AFR and the overall survival (OS) in lung cancer patients. Methods: The levels of pre-treatment AFR were retrospectively analyzed with clinical parameters, metastasis and survival status in 437 patients with lung cancer. Kaplan‐Meier test and Cox regression analysis were introduced to evaluate the prognosis effect of AFR on OS. Results: The pre-treatment AFR was significantly associated with gender, smoking status, tumor stage, bone and lymph node metastasis, operation, chemotherapy and some laboratory measurements (All P < 0.05). Patients with high AFR had better survival in Kaplan–Meier curve (p < 0.001). In univariate analysis, AFR, age, TNM stage, operation, Chemotherapy, smoking status, brain, bone, liver, lymph node and mediastina metastasis were significant prognostic factors for OS. However, the multivariate Cox regression analysis showed that elevated AFR was correlated with a favorable OS (HR: 0.542, 95% CI: 0.388 - 0.759, P < 0.001). Conclusions: AFR could be considered as an independent prognostic factor in lung cancer.
What problem does this paper attempt to address?